Stryker sells U.S. spinal implants business to Viscogliosi Brothers

Stryker sells U.S. spinal implants business to Viscogliosi Brothers

USA – In a shift from its usual acquisition strategy, Stryker, a leading medical device company, has announced the sale of its U.S. spinal implants business to Viscogliosi Brothers (VB), an investment firm specializing in neuro-musculoskeletal solutions. This division will now operate as part of a newly formed company called VB Spine. Additionally, the deal […]

Zimmer Biomet to acquire foot and ankle specialist Paragon 28 for US $1.2 billion

Zimmer Biomet to acquire foot and ankle specialist Paragon 28 for US 1.2 billion

USA – Zimmer Biomet, a global leader in musculoskeletal healthcare, has announced plans to acquire Paragon 28, a medical device company specializing in foot and ankle orthopedic solutions. The deal, valued at approximately US $1.2 billion, will involve Zimmer Biomet purchasing all outstanding shares of Paragon 28 at US $13 per share in cash. Founded […]

GE HealthCare invests US $138M to expand contrast media production in Ireland

GE HealthCare invests US 138M to expand contrast media production in Ireland

IRELAND – GE HealthCare has announced a significant US $138 million investment to expand its contrast media manufacturing site in Carrigtohill, Cork, Ireland. This new facility, to be built on the current site, will increase production capacity, enabling 25 million more patient doses of contrast media each year by 2027. This expansion aims to meet […]

NHS launches AI trial for breast cancer screening

NHS launches AI trial for breast cancer screening

U.K. – The National Health Service (NHS) has unveiled a groundbreaking trial to test artificial intelligence (AI) tools in breast cancer screening, aiming to detect the disease earlier and save lives. Nearly 700,000 women will be invited to participate in this trial, called the EDITH (Early Detection using Information Technology in Health) study, which was […]

Pharma groups warn US tariffs could raise drug costs and worsen shortages

Pharma groups warn US tariffs could raise drug costs and worsen shortages

USA – US pharmaceutical trade organizations are cautioning that new tariffs, such as the 10% levy on Chinese imports, could significantly impact the healthcare sector by increasing drug costs, disrupting supply chains, and worsening existing drug shortages. These concerns were raised by the Association for Accessible Medicines (AAM), which represents generic and biosimilar medicine manufacturers, […]

Thermo Fisher unveils new electrochemistry bench meters

Thermo Fisher unveils new electrochemistry bench meters

USA – Thermo Fisher Scientific has introduced the Orion Pro Star electrochemistry bench meter series, a cutting-edge solution designed to deliver precise and reliable results for a variety of industries. With advanced features and a user-friendly interface, these meters aim to make electrochemistry testing easier and more efficient. The Orion Pro Star series has been […]

Pfizer’s colorectal cancer drug gains momentum with promising data

Pfizer’s colorectal cancer drug gains momentum with promising data

USA – Pfizer recently received accelerated approval from the FDA for its combination therapy based on Braftovi (encorafenib) to treat colorectal cancer, and new survival data may soon lead to full approval. The combination therapy includes Braftovi, Eli Lilly’s Erbitux (cetuximab), and chemotherapy, specifically targeting patients with BRAF V600E-mutated metastatic colorectal cancer. Results from the […]

EMA supports approval of Bavarian Nordic’s vaccine for Chikungunya

EMA supports approval of Bavarian Nordic’s vaccine for Chikungunya

NETHERLANDS – The European Medicines Agency (EMA) has taken a significant step in the fight against chikungunya, with its human medicines committee recommending approval for Bavarian Nordic’s vaccine, Vimkunya. This vaccine is set to become the first option in the EU to protect both adolescents (from the age of 12) and adults against chikungunya, a […]

Nations back WHO, advocate diplomacy to bring US back on board

Nations back WHO, advocate diplomacy to bring US back on board

SWITZERLAND – At a recent World Health Organization (WHO) executive board meeting, member states showed strong support for the organization despite the United States’ decision to withdraw. However, many countries urged diplomatic efforts to encourage the US to reconsider its exit. Israel, a close ally of the US, pointed out that while the loss of […]

AbbVie adjusts strategy for schizophrenia drug after Phase II setback

AbbVie adjusts strategy for schizophrenia drug after Phase II setback

USA – AbbVie is recalibrating its approach to its schizophrenia treatment, emraclidine, after it failed two Phase II trials in late 2024. The company has decided to focus on developing emraclidine as an adjunct treatment, meaning it will be combined with existing therapies for schizophrenia, rather than pursuing it as a stand-alone therapy for now. […]

Sanofi-backed AdvanCell raises US $112 million in Series C funding

Sanofi backed AdvanCell raises US 112 million in Series C funding

AUSTRALIA – AdvanCell, an Australian radiopharmaceutical company, has raised US $112 million in a Series C funding round, backed by Sanofi Ventures, as it progresses its lead candidate through a clinical trial for prostate cancer. This investment will help the company take its promising treatments closer to commercialization. The core of AdvanCell’s technology is its […]

Thermo Fisher announces further job cuts as part of restructuring efforts

Thermo Fisher announces further job cuts as part of restructuring efforts

USA – Thermo Fisher Scientific is set to lay off 300 employees at two of its Massachusetts facilities as the company restructures its viral vector production network. The layoffs, which will take effect on March 30, were revealed in a Massachusetts Worker Adjustment and Retraining Notification (WARN) last week. These cuts will affect workers at […]